Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea
Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Lung Neoplasms

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chevallierdagger, B; Chollet, P; Coudert, B; Fumoleau, P; Hanauske, A; Lentz, M; Ouabdesselam, R; Rebattu, P; Schneider, M1

Trials

1 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Lung Neoplasms

ArticleYear
[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma].
    Revue de pneumologie clinique, 2000, Volume: 56, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitrosourea Compounds; Palliative Care

2000